Home dialysis/home therapies issues
Improving Access to Dialysis Act
Living Donor Protection Act (H.R. 2923/S. 1384)
FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research
FY 2024 funding kidney disease research at NIDDK at NIH
Funding for Kidney X program at HHS
Funding for AHRQ at HHS
Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668)
National Nursing Workforce Center Act (H.R. 2411/S. 1150)
Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176)
Living Donor Protection Act (H.R. 2923/S. 1384)
Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027)
Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074)
Restore Protections for Dialysis Patients Act (H.R. 6860)
Living Organ Donor Tax Credit Act (H.R. 6171)
Honor Our Living Donors Act (H.R. 6020)
Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211)
Restore Protections for Dialysis Patients Act (H.R. 6860)
Future Advancement of Academic Nursing Act (H.R. 7266 / S. 3770)
Duration: January 18, 2022
to
present
General Issues: Health Issues , Budget/Appropriations
Spending: about $270,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on April 22.
Original Filing: 301575515.xml
Lobbying Issues
Home dialysis/home therapies issues
Improving Access to Dialysis Act
Living Donor Protection Act (H.R. 2923/S. 1384)
FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research
FY 2024 funding kidney disease research at NIDDK at NIH
Funding for Kidney X program at HHS
Funding for AHRQ at HHS
Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668)
National Nursing Workforce Center Act (H.R. 2411/S. 1150)
Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176)
Living Donor Protection Act (H.R. 2923/S. 1384)
Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027)
Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074)
Restore Protections for Dialysis Patients Act (H.R. 6860)
Living Organ Donor Tax Credit Act (H.R. 6171)
Honor Our Living Donors Act (H.R. 6020)
Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211)
Restore Protections for Dialysis Patients Act (H.R. 6860)
Future Advancement of Academic Nursing Act (H.R. 7266 / S. 3770)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on Jan. 20.
Original Filing: 301533827.xml
Lobbying Issues
Home dialysis/home therapies issues
Improving Access to Dialysis Act
Living Donor Protection Act (H.R. 2923/S. 1384)
FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research
FY 2024 funding kidney disease research at NIDDK at NIH
Funding for Kidney X program at HHS
Funding for AHRQ at HHS
Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668)
National Nursing Workforce Center Act (H.R. 2411/S. 1150)
Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176)
Living Donor Protection Act (H.R. 2923/S. 1384)
Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027)
Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074)
Restore Protections for Dialysis Patients Act (H.R. 6860)
Living Organ Donor Tax Credit Act (H.R. 6171)
Honor Our Living Donors Act (H.R. 6020)
Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on Oct. 20, 2023.
Original Filing: 301510564.xml
Lobbying Issues
Home dialysis/home therapies issues; Improving Access to Dialysis Act; Living Donor Protection Act (H.R. 2923/S. 1384); FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research; FY 2024 funding kidney disease research at NIDDK at NIH; Funding for Kidney X program at HHS; Funding for AHRQ at HHS; Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668); National Nursing Workforce Center Act (H.R. 2411/S. 1150); Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176); Living Donor Protection Act (H.R. 2923/S. 1384); Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on July 19, 2023.
Original Filing: 301484875.xml
Lobbying Issues
Home dialysis/home therapies issues; Improving Access to Dialysis Act; Living Donor Protection Act (H.R. 2923/S. 1384); FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research; FY 2024 funding kidney disease research at NIDDK at NIH; Funding for Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS; Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668); National Nursing Workforce Center Act (H.R. 2411/S. 1150); Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on April 20, 2023.
Original Filing: 301465291.xml
Lobbying Issues
Home dialysis/home therapies issues; Improving Access to Dialysis Act; Chronic Kidney Disease Improvement Act; CONNECT Act; Living Donor Protection Act; US Cadet Nurse Corps Service Recognition Act; FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research; FY 2024 funding kidney disease research at NIDDK at NIH; Funding for Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on Jan. 20, 2023.
Original Filing: 301440791.xml
Lobbying Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 funding kidney disease research at NIDDK at NIH; Funding for the Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS.
3rd Quarter, 2022
In Q3, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411199.xml
Lobbying Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
FY 2023 funding kidney disease research at NIDDK at NIH; Funding for the Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS.
2nd Quarter, 2022
In Q2, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301387816.xml
Lobbying Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
FY 2023 funding kidney disease research at NIDDK at NIH; Funding for the Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS.
1st Quarter, 2022
In Q1, Venable LLP lobbied for American Nephrology Nurses Association , earning $30,000. The report was filed on April 19, 2022.
Original Filing: 301364204.xml
Lobbying Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Lobbying Issues
FY 2022 funding on chronic kidney disease prevention at CDC; Funding kidney disease research at NIDDK at NIH; Funding for the Kidney X program at HHS; Funding for nursing workforce programs and AHRQ at HHS.
1st Quarter, 2022
Venable LLP filed a lobbying registration on March 28, 2022 to represent American Nephrology Nurses Association, effective Jan. 18, 2022.
Original Filing: 301343041.xml
Issue(s) they said they’d lobby about: Nursing Workforce Development funding, Medicare ESRD program, and biomedical research funding .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate